The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.

@article{Montagnani2008TheEO,
  title={The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer.},
  author={Andrea Montagnani and Stefano Gonnelli and Alice Cadirni and Carla Caffarelli and K Del Santo and C Pieropan and Maria Stella Campagna and Marco Montomoli and Roberto Petrioli and Ranuccio Nuti},
  journal={European journal of internal medicine},
  year={2008},
  volume={19 8},
  pages={592-7}
}
BACKGROUND The third-generation aromatase inhibitor exemestane represents a new development in the treatment of estrogen-positive breast cancer. The aim of this study was to evaluate the effects on lipid profile and body composition of the shift from tamoxifen to exemestane. METHODS After 2-3 years of tamoxifen adjuvant treatment, 68 postmenopausal women were randomly assigned to either continue tamoxifen 20 mg/day (n = 35) or to switch to exemestane 25 mg/day (n = 33). RESULTS No… CONTINUE READING
7 Citations
27 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Effects of anastrozole on the lipid profile in postmenopausal breast cancer patients—a preliminary study

  • Y Hozumi, T Saito, K Inoue, M Saiozawa, Y Omoto, T Tabey
  • Eur J Cancer
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…